CN101966226B - Chinese medicinal composition for treating heart cerebrovascular diseases - Google Patents
Chinese medicinal composition for treating heart cerebrovascular diseases Download PDFInfo
- Publication number
- CN101966226B CN101966226B CN2010105046840A CN201010504684A CN101966226B CN 101966226 B CN101966226 B CN 101966226B CN 2010105046840 A CN2010105046840 A CN 2010105046840A CN 201010504684 A CN201010504684 A CN 201010504684A CN 101966226 B CN101966226 B CN 101966226B
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicinal
- medicinal composition
- powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention discloses a Chinese medicinal composition for treating heart cerebrovascular diseases. The Chinese medicinal composition is powder or powder capsules prepared by mixing the following raw medicaments in part by weight: 1 part of pseudo-ginseng, 0.5 to 1.5 parts of safflower, 0.1 to 0.9 part of leech, 1 to 2 parts of root of red-rooted salvia, 0.5 to 1.5 parts of earthworm, 1 to 2 parts of Chinese angelica, 1 to 2 parts of white paeony root, 0.4 to 1.2 parts of szechuan lovage rhizome, 0.8 to 2 parts of twotooth achyranthes root, 1 to 2 parts of ramulus uncariae, 0.5 to 1.5 parts of tuber, 0.5 to 1.5 parts of platycladi seed, 0.05 to 0.3 part of cinnabar, and 0.05 to 0.4 part of borneol. The Chinese medicinal composition for treating heart cerebrovascular diseases has the characteristics that: the Chinese medicinal composition has quick effect on dizziness and vertigo caused by chronic cerebral circulation insufficiency, after a patient takes the medicament 3 to 10 minutes later, a symptom can be removed, the patient keeps a cool head and feels so much better; and if the patient takes the medicament continuously for a week, the symptoms of dizziness and vertigo are removed in one month, so that the Chinese medicinal composition is favorable for the healthcare of aged and elderly people, and the patient who has cerebral hemorrhage mild sequela, such as the symptoms of hands and foot numbness, weakness in walking and the like, can recover after the patient takes the medicament continuously in 5 to 9 months.
Description
Technical field the invention belongs to a kind of Chinese medicine composition for the treatment of cardiovascular and cerebrovascular disease.
Background technology is for most of middle-aged and elderly people, and owing to age growth, physical function are degenerated, organ blood supply insufficiencies such as heart and brain usually can feel dizzy and with one's eyesight blurred, and are perhaps drowsy.This is the symptom of typical cerebral ischemia.And cerebral ischemia in other words blood supply insufficiency be because the problem of blood itself, and blood vessel wall thickening, pipeline narrow down, and mental and physical efforts decline, under the pump blood volume due to the many factors of degradation.Blood supply insufficiency of brain also can cause head organ generation pathological changes such as eyes, as cataract etc.
The Chinese medicine Western medicine that is used to improve cardiac and cerebral blood-supply is all more, but biases toward curative effect in a certain respect mostly, certain toxic and side effects is often arranged, and it is slower to take effect, and the drug effect phase is short, and dosage is big, the course of treatment is long.
Summary of the invention purpose of the present invention be exactly propose a kind of rapid-action, dosage is little, the course of treatment is short, the Chinese medicine composition of the cardiovascular and cerebrovascular disease that has no side effect, to remedy the deficiency of existing medicine.
The Chinese medicine composition of this treatment cardiovascular and cerebrovascular disease that the present invention proposes is characterized in that it is powder or the powder capsule that is mixed by following former medicine by weight:
1 part of Radix Notoginseng; Flos Carthami 0.5-1.5 part; Hirudo 0.1-0.9 part; Radix Salviae Miltiorrhizae 1-2 part; Pheretima 0.5-1.5 part.And with 1 part of Radix Notoginseng; 1 part on Flos Carthami; 0.4 part of Hirudo; 1.5 parts of Radix Salviae Miltiorrhizaes; The proportioning that Pheretima is 1 part is good.
Also can add Radix Angelicae Sinensis 1-2 part; Radix Paeoniae Alba 1-2 part, Rhizoma Chuanxiong 0.4-1.2 part.And with 1 part of Radix Notoginseng; 1 part on Flos Carthami; 0.4 part of Hirudo; 1.5 parts of Radix Salviae Miltiorrhizaes; 1 part of Pheretima; 1.5 parts of Radix Angelicae Sinensis; 1.5 parts of the Radix Paeoniae Albas, the proportioning that Rhizoma Chuanxiong is 0.8 part are good.
Can also add Radix Achyranthis Bidentatae 0.8-2 part; Ramulus Uncariae Cum Uncis 1-2 part; Radix Curcumae 0.5-1.5 part.And with 1 part of Radix Notoginseng; 1 part on Flos Carthami; 0.4 part of Hirudo; 1.5 parts of Radix Salviae Miltiorrhizaes; 1 part of Pheretima; 1.5 parts of Radix Angelicae Sinensis; 1.5 parts of the Radix Paeoniae Albas, 0.8 part of Rhizoma Chuanxiong; 1.2 parts of Radix Achyranthis Bidentataes; 1.5 parts of Ramulus Uncariae Cum Uncis; The proportioning that Radix Curcumae is 1 part is good.
Also can add Semen Platycladi 0.5-1.5 part; Cinnabaris 0.05-0.3 part; Borneolum Syntheticum 0.05-0.4 part.And with 1 part of Radix Notoginseng; 1 part on Flos Carthami; 0.4 part of Hirudo; 1.5 parts of Radix Salviae Miltiorrhizaes; 1 part of Pheretima; 1.5 parts of Radix Angelicae Sinensis; 1.5 parts of the Radix Paeoniae Albas, 0.8 part of Rhizoma Chuanxiong; 1.2 parts of Radix Achyranthis Bidentataes; 1.5 parts of Ramulus Uncariae Cum Uncis; 1 part of Radix Curcumae; 1 part of Semen Platycladi; 0.1 part in Cinnabaris; The proportioning that Borneolum Syntheticum is 0.2 part is good.
Unless specifically stated otherwise, flavour of a drug of the present invention are the dried medicine of former medicine, for the conventional sales in the shop of Chinese medicines or be equal to product.Flavour of a drug umber of the present invention is weight portion.
Medicine of the present invention, how based on powder or title powder and capsule, powder is auxilliary.Powder in the capsule is a powder.Dress 0.5g powder in every capsules.Warm water delivery service, each 4-5 grain, day clothes secondary.
The giddy that characteristics of the present invention are cerebral blood supply insufficiency is caused, dizzy quick curative effect arranged, symptom can be eliminated in 3-10 minute in the back of taking medicine, and recovered clearheaded, a feel spirit and QI cleaning.Serveing on an a Monday month Nei Kebao does not have dizzy dizzy.Very useful to the middle-aged and old health.For the slight sequela of cerebral hemorrhage cerebral thrombosis,, walk and unablely wait disease in continuing to take medicine 5-9 month, to recover normal as foot hands hemiplegia, numbness.
Further specify positive therapeutic of the present invention below in conjunction with actual case.
Specific embodiment example 1, field, woman, 35 years old, Han nationality, Yang Jie town, Jianshui County, Yunnan peasant.Over 4 years, usually dizzy headache does not have obvious focus to examination in hospital, is diagnosed as cerebral blood supply insufficiency.Ate many Western medicine and Chinese medicine, symptom can not be eliminated all the time.In April, 2007 examination clothes powder capsule of the present invention disappeared less than symptom in one month entirely.
Example 2, Zhang, man, 39 years old, Hani, Yunnan amount county croak ma township peasant.Unknown dizzy headache is more than 8 years.The normal prescription on individual diagnosis to commune hospital, township county hospital treated.It is countless to take medicine, and does not have effect.Begin to take powder capsule of the present invention in August, 2008.The symptom that serve on a dizzy headache in month has disappeared entirely, later on not take medicine, does not see recurrence so far again.
Example 3, Zhang, the man, 65 years old, Han nationality, Jianshui County, Yunnan peasant causes injury because of climbing tree to throw accidentally.Often dizzy headache, the eyeball distending pain has all been seen to some large hospitals in county hospital, Kunming, and just disconnected is that intraocular pressure is too high, suspect glaucoma, hospital claims and can't control that patient have to disappointedly go home.After seek medical advice everywhere again, seek herbalist's good recipe among the people, but all end without result.In June, 2008 examination clothes powder capsule of the present invention.When taking medicine then October, the patient feels no longer distending pain of eyeball, and giddy has also disappeared unawares.
The medicine water spray of the used powder capsule of patient of example 1-3 consists of: 1 part of Radix Notoginseng; 1 part on Flos Carthami; 0.4 part of Hirudo; 1.5 parts of Radix Salviae Miltiorrhizaes; 1 part of Pheretima.More than fineness 100 orders of powder.Dosage is every 0.5g, warm water delivery service, each 4-5 grain, day clothes secondary.
Curative effect situation when in following scope, changing for the proportioning of flavour of a drug, through symptom and degree therewith three examples similar 30 surplus a patient on probation, prove that flavour of a drug all can have obvious curative effects when range a bit.Effective percentage reaches more than 95%, has no side effect:
1 part of Radix Notoginseng; Flos Carthami 0.5-1.5 part; Hirudo 0.1-0.9 part; Radix Salviae Miltiorrhizae 1-2 part; Pheretima 0.5-1.5 part.
Example 4, Chen, the woman, 66 years old, Han nationality, slope, Kaiyuan City Dongshan, Yunnan peasant, the right migraine was had a surplus in 8 years, and the doctor trained in Western medicine traditional Chinese medical science has all been seen.Ate a lot of medicines, and there is no effect, migrainous torment still.Take powder capsule of the present invention in June, 2007, and when adhering to taking then JIUYUE, symptom has suddenly disappeared.After do not recommit.
Example 5, Zhao so-and-so, man, 58 years old, the Yi nationality, distributed over Yunnan, Sichuan and Guizhou, Shiping County, Yunnan dragon friend town peasant, dizzy always headache behind cold, fever before 3 years.To the township, the county hospital diagnosis and treatment repeatedly all fail to remove ailing.Begin to take powder capsule of the present invention in March, 2008, serve on May then, and disease all disappears, after do not see recurrence.
Example 6, king so-and-so, man, 61 years old, Han nationality, cold spring township, Mengzi County, Yunnan peasant, giddy is dizzy, the left hand foot numbness is many half a year.To township's county hospital diagnosis and treatment, due to the cerebral blood supply insufficiency of saying so, there is not specific drug, the doctor does not have positive effect after eating for the medicine of having opened some relief of symptoms, and symptom is still.Take powder capsule of the present invention in May, 2009, transference cure when taking then August, physical recovery normal.
The used flavour of a drug of example 4-6 patient are formed: 1 part of Radix Notoginseng; 1 part on Flos Carthami; 0.4 part of Hirudo; 1.5 parts of Radix Salviae Miltiorrhizaes; 1 part of Pheretima; 1.5 parts of Radix Angelicae Sinensis; 1.5 parts of the Radix Paeoniae Albas, 0.8 part of Rhizoma Chuanxiong.All the other are with routine 1-3.
Curative effect situation when in following scope, changing for the proportioning of flavour of a drug, through symptom and degree similar to routine 4-6 50 surplus a patient on probation, prove that flavour of a drug all can have obvious curative effects when these range.Effective percentage reaches more than 95%, has no side effect.
1 part of Radix Notoginseng; Flos Carthami 0.5-1.5 part; Hirudo 0.1-0.9 part; Radix Salviae Miltiorrhizae 1-2 part; Pheretima 0.5-1.5 part; Radix Angelicae Sinensis 1-2 part; Radix Paeoniae Alba 1-2 part, Rhizoma Chuanxiong 0.4-1.2 part.
Example 7, Lee so-and-so, the woman, 68 years old, Han nationality, Lao Chang town, Gejiu, Yunnan peasant, dizzy headache 2 years is surplus.To the grand administrative barnyard in town and the diagnosis and treatment of city institute of traditional Chinese medicine repeatedly, claim no obvious focus, due to the doubtful cerebral blood supply insufficiency.Each all be out to dredge a bit the drug administration that muscle is invigorated blood circulation and so on, but DeGrain, slight illness is puzzled all the time.In July, 2008, take powder capsule of the present invention.Serve on and cured in three weeks, after do not see recurrence.
Example 8, Yang, the man, 72 years old, the Yi nationality, distributed over Yunnan, Sichuan and Guizhou, Bao He township, Gejiu, the Yunnan peasant of Semen Juglandis stockaded village, often dizzy, dizzy.Seek medical advice repeatedly to commune hospital, township and city institute of traditional Chinese medicine, do not get well all the time.Take powder capsule of the present invention in February, 2009, the drug withdrawal of recovering after serveing on 4 months.After the recurrence.
Example 9, grandson so-and-so, the man, 59 years old, Hani, Honghe County, Yunnan peasant, apoplexy sequela, left side trick is unable, it is ineffective to take action.Take powder capsule of the present invention in March, 2009, recover former strong to conscious trick in June then, it is also normal to take action.
The used flavour of a drug of patient of example 7-9 are formed: 1 part of Radix Notoginseng; 1 part on Flos Carthami; 0.4 part of Hirudo; 1.5 parts of Radix Salviae Miltiorrhizaes; 1 part of Pheretima; 1.5 parts of Radix Angelicae Sinensis; 1.5 parts of the Radix Paeoniae Albas, 0.8 part of Rhizoma Chuanxiong; 1.2 parts of Radix Achyranthis Bidentataes; 1.5 parts of Ramulus Uncariae Cum Uncis; 1 part of Radix Curcumae.All the other are with routine 1-3.
Curative effect situation when in following scope, changing for the proportioning of flavour of a drug, through symptom and degree similar to routine 7-9 60 surplus a patient on probation, prove that flavour of a drug all can have obvious curative effects when these range.Effective percentage reaches more than 93%, has no side effect.
1 part of Radix Notoginseng; Flos Carthami 0.5-1.5 part; Hirudo 0.1-0.9 part; Radix Salviae Miltiorrhizae 1-2 part; Pheretima 0.5-1.5 part; Radix Angelicae Sinensis 1-2 part; Radix Paeoniae Alba 1-2 part, Rhizoma Chuanxiong 0.4-1.2 part; Radix Achyranthis Bidentatae 0.8-2 part; Ramulus Uncariae Cum Uncis 1-2 part; Radix Curcumae 0.5-1.5 part.
Example 10, Zheng, the man, 71 years old, Han nationality, Yunnan Jin Pingxian peasant suffers from cerebral hemorrhage and falls sequela, left half of health numbness, trick is ice-cold, belongs to cerebral blood supply insufficiency.Take powder capsule of the present invention in May, 2008, the numb disappearance when serveing on then JIUYUE, and trick recovers to have normal temperature, warm feeling.
Example 11, Zhu, the man, 73 years old, Han nationality, Jiangchuan County, Yunnan peasant, cerebral infarction sequela, left half of health is numb to be wanted, and trick is unable.In JIUYUE, 2008 is taken powder capsule of the present invention, in May, 2009, and numb the elimination, it is normal that trick recovers substantially.
Example 12, Yang, the man, 68 years old, Han nationality, retired employees of Yun Xijian peace company, apoplexy sequela, left side trick is unable, the sialorrhea of speaking, it is unclear to tell sound.Take powder capsule of the present invention in November, 2008, and trick recovers normal when taking in June, 2009, and grasping is strong, walk as before, and artistomia, saliva is also more preceding much fewer.
The used flavour of a drug of patient of example 10-12 are formed: 1 part of Radix Notoginseng; 1 part on Flos Carthami; 0.4 part of Hirudo; 1.5 parts of Radix Salviae Miltiorrhizaes; 1 part of Pheretima; 1.5 parts of Radix Angelicae Sinensis; 1.5 parts of the Radix Paeoniae Albas, 0.8 part of Rhizoma Chuanxiong; 1.2 parts of Radix Achyranthis Bidentataes; 1.5 parts of Ramulus Uncariae Cum Uncis; 1 part of Radix Curcumae; 1 part of Semen Platycladi; 0.1 part in Cinnabaris; 0.2 part of Borneolum Syntheticum.Surplus with routine 1-3.
Curative effect situation when in following scope, changing for the proportioning of flavour of a drug, through symptom and degree similar to routine 10-12 70 surplus a patient on probation, prove that flavour of a drug all can have obvious curative effects when these range.Effective percentage reaches more than 95%, has no side effect.
1 part of Radix Notoginseng; Flos Carthami 0.5-1.5 part; Hirudo 0.1-0.9 part; Radix Salviae Miltiorrhizae 1-2 part; Pheretima 0.5-1.5 part; Radix Angelicae Sinensis 1-2 part; Radix Paeoniae Alba 1-2 part, Rhizoma Chuanxiong 0.4-1.2 part; Radix Achyranthis Bidentatae 0.8-2 part; Ramulus Uncariae Cum Uncis 1-2 part; Radix Curcumae 0.5-1.5 part; Semen Platycladi 0.5-1.5 part; Cinnabaris 0.05-0.3 part; Borneolum Syntheticum 0.05-0.4 part.
Claims (6)
1. Chinese medicine composition for the treatment of cardiovascular and cerebrovascular disease is characterized in that it is powder or the powder capsule that is mixed by following former medicine by weight:
1 part of Radix Notoginseng; Flos Carthami 0.5-1.5 part; Hirudo 0.1-0.9 part; Radix Salviae Miltiorrhizae 1-2 part; Pheretima 0.5-1.5 part; Radix Angelicae Sinensis 1-2 part; Radix Paeoniae Alba 1-2 part, Rhizoma Chuanxiong 0.4-1.2 part.
2. the Chinese medicine composition of treatment cardiovascular and cerebrovascular disease according to claim 1 is characterized in that the weight portion proportioning of each flavour of a drug is: 1 part of Radix Notoginseng; 1 part on Flos Carthami; 0.4 part of Hirudo; 1.5 parts of Radix Salviae Miltiorrhizaes; 1 part of Pheretima; 1.5 parts of Radix Angelicae Sinensis; 1.5 parts of the Radix Paeoniae Albas, 0.8 part of Rhizoma Chuanxiong.
3. Chinese medicine composition for the treatment of cardiovascular and cerebrovascular disease is characterized in that it is powder or the powder capsule that is mixed by following former medicine by weight:
1 part of Radix Notoginseng; Flos Carthami 0.5-1.5 part; Hirudo 0.1-0.9 part; Radix Salviae Miltiorrhizae 1-2 part; Pheretima 0.5-1.5 part; Radix Angelicae Sinensis 1-2 part; Radix Paeoniae Alba 1-2 part, Rhizoma Chuanxiong 0.4-1.2 part; Radix Achyranthis Bidentatae 0.8-2 part; Ramulus Uncariae Cum Uncis 1-2 part; Radix Curcumae 0.5-1.5 part.
4. the Chinese medicine composition of treatment cardiovascular and cerebrovascular disease according to claim 3 is characterized in that the weight portion proportioning of each flavour of a drug is: 1 part of Radix Notoginseng; 1 part on Flos Carthami; 0.4 part of Hirudo; 1.5 parts of Radix Salviae Miltiorrhizaes; 1 part of Pheretima; 1.5 parts of Radix Angelicae Sinensis; 1.5 parts of the Radix Paeoniae Albas, 0.8 part of Rhizoma Chuanxiong; 1.2 parts of Radix Achyranthis Bidentataes; 1.5 parts of Ramulus Uncariae Cum Uncis; 1 part of Radix Curcumae.
5. Chinese medicine composition for the treatment of cardiovascular and cerebrovascular disease is characterized in that it is powder or the powder capsule that is mixed by following former medicine by weight:
1 part of Radix Notoginseng; Flos Carthami 0.5-1.5 part; Hirudo 0.1-0.9 part; Radix Salviae Miltiorrhizae 1-2 part; Pheretima 0.5-1.5 part; Radix Angelicae Sinensis 1-2 part; Radix Paeoniae Alba 1-2 part, Rhizoma Chuanxiong 0.4-1.2 part; Radix Achyranthis Bidentatae 0.8-2 part; Ramulus Uncariae Cum Uncis 1-2 part; Radix Curcumae 0.5-1.5 part; Semen Platycladi 0.5-1.5 part; Cinnabaris 0.05-0.3 part; Borneolum Syntheticum 0.05-0.4 part.
6. the Chinese medicine composition of treatment cardiovascular and cerebrovascular disease according to claim 5 is characterized in that the weight portion proportioning of each flavour of a drug is: 1 part of Radix Notoginseng; 1 part on Flos Carthami; 0.4 part of Hirudo; 1.5 parts of Radix Salviae Miltiorrhizaes; 1 part of Pheretima; 1.5 parts of Radix Angelicae Sinensis; 1.5 parts of the Radix Paeoniae Albas, 0.8 part of Rhizoma Chuanxiong; 1.2 parts of Radix Achyranthis Bidentataes; 1.5 parts of Ramulus Uncariae Cum Uncis; 1 part of Radix Curcumae; 1 part of Semen Platycladi; 0.1 part in Cinnabaris; 0.2 part of Borneolum Syntheticum.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010105046840A CN101966226B (en) | 2010-10-08 | 2010-10-08 | Chinese medicinal composition for treating heart cerebrovascular diseases |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010105046840A CN101966226B (en) | 2010-10-08 | 2010-10-08 | Chinese medicinal composition for treating heart cerebrovascular diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101966226A CN101966226A (en) | 2011-02-09 |
| CN101966226B true CN101966226B (en) | 2011-09-28 |
Family
ID=43545488
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010105046840A Expired - Fee Related CN101966226B (en) | 2010-10-08 | 2010-10-08 | Chinese medicinal composition for treating heart cerebrovascular diseases |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101966226B (en) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102657711B (en) * | 2012-05-29 | 2013-08-07 | 昆明肾脏病研究所 | Cerebral apoplexy treatment medicament and preparation method thereof |
| CN102940706A (en) * | 2012-09-19 | 2013-02-27 | 荣成市崖头美全口腔诊所 | Traditional Chinese medicine composition for treating fundus hemorrhage |
| CN103230443B (en) * | 2013-04-23 | 2015-09-16 | 周术凯 | Treat hypertensive Chinese medicine composition |
| CN105079103A (en) * | 2014-05-09 | 2015-11-25 | 宋修文 | Traditional Chinese medicine preparation for preventing and treating thrombus |
| CN104225507A (en) * | 2014-10-13 | 2014-12-24 | 崔银方 | Chinese medicine for treating limb paralysis and pain caused by cerebral hemorrhage |
| CN104435427A (en) * | 2014-11-24 | 2015-03-25 | 毛华养 | Medicinal wine for promoting traumatic injury recovery |
| CN105031522B (en) * | 2015-07-11 | 2018-06-05 | 王立财 | One kind is cured brain psychological treatment object |
| CN105250765A (en) * | 2015-10-30 | 2016-01-20 | 青岛麦瑞特医药技术有限公司 | Traditional Chinese medicinal preparation for treating acute cerebral hemorrhage and preparation method of traditional Chinese medicinal preparation |
| CN105535099A (en) * | 2016-01-02 | 2016-05-04 | 红河州吉昌生物科技有限公司 | Vasodistal biological medicine preparation |
| CN107334961A (en) * | 2017-08-04 | 2017-11-10 | 绿都中草药研发中心（北京）有限公司 | A kind of preparation of prophylactic treatment cardiovascular and cerebrovascular disease and application |
| CN108743872A (en) * | 2018-07-19 | 2018-11-06 | 江苏霍氏医药科技有限公司 | A kind of brain Maitong liquid and preparation method thereof |
| CN109276638A (en) * | 2018-12-12 | 2019-01-29 | 张进山 | A kind of Chinese medicine dipping semen sojae atricolor and preparation method thereof for treating cardiovascular and cerebrovascular disease |
| CN110237211A (en) * | 2019-05-16 | 2019-09-17 | 杨会明 | A kind of Chinese materia medica preparation and preparation method thereof for treating cardiovascular and cerebrovascular |
| CN112656883B (en) * | 2020-12-21 | 2022-01-28 | 黑龙江儒泰科技发展有限责任公司 | Traditional Chinese medicine composition for treating ischemic cerebrovascular disease and application thereof |
| CN113384659A (en) * | 2021-07-28 | 2021-09-14 | 贵州百里杜鹃奇特梦食品开发有限公司 | Traditional Chinese medicine formula for treating cardiovascular and cerebrovascular obstructed cerebral hemorrhage |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1401347A (en) * | 2001-09-07 | 2003-03-12 | 孙守贵 | Brain and heart recovery pill |
| CN1528395A (en) * | 2003-10-14 | 2004-09-15 | 李天兰 | Fatty-reducing paster |
| CN1990013A (en) * | 2005-12-26 | 2007-07-04 | 王学忠 | Traditional Chinese medicine for vein relaxing and blood consistence reducing |
| CN101085012A (en) * | 2006-06-08 | 2007-12-12 | 天津天士力制药股份有限公司 | Composition containing safflower for treating cardiovascular diseases and its preparation |
| CN101829148A (en) * | 2009-03-10 | 2010-09-15 | 李振国 | Traditional Chinese medicine extractive, oral preparation containing extractive and method for preparing oral preparation |
-
2010
- 2010-10-08 CN CN2010105046840A patent/CN101966226B/en not_active Expired - Fee Related
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1401347A (en) * | 2001-09-07 | 2003-03-12 | 孙守贵 | Brain and heart recovery pill |
| CN1528395A (en) * | 2003-10-14 | 2004-09-15 | 李天兰 | Fatty-reducing paster |
| CN1990013A (en) * | 2005-12-26 | 2007-07-04 | 王学忠 | Traditional Chinese medicine for vein relaxing and blood consistence reducing |
| CN101085012A (en) * | 2006-06-08 | 2007-12-12 | 天津天士力制药股份有限公司 | Composition containing safflower for treating cardiovascular diseases and its preparation |
| CN101829148A (en) * | 2009-03-10 | 2010-09-15 | 李振国 | Traditional Chinese medicine extractive, oral preparation containing extractive and method for preparing oral preparation |
Non-Patent Citations (4)
| Title |
|---|
| 潘志伟等.中药复方治疗冠心病心绞痛研究现状.《实用中医药杂志》.2010,第26卷(第3期),204-205. * |
| 潘志伟等.中药复方治疗冠心病心绞痛研究现状.<<实用中医药杂志>>.2010,第26卷(第3期),204-205. |
| 谢玲芳.中医药治疗心绞痛综述.《福建中医学院学报》.2007,第17卷(第5期),70-72. * |
| 谢玲芳.中医药治疗心绞痛综述.<<福建中医学院学报>>.2007,第17卷(第5期),70-72. |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101966226A (en) | 2011-02-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101966226B (en) | Chinese medicinal composition for treating heart cerebrovascular diseases | |
| CN101940743B (en) | Chinese medicament for treating gastrosis and preparation method thereof | |
| CN104398982A (en) | Traditional Chinese medicine composition for treating traumatic injury and joint pain and swelling | |
| CN101444617A (en) | Traditional Chinese medicine formula for oral administration used for treating arrhythmia | |
| CN103495009B (en) | Traditional Chinese medicine for treating coronary heart disease | |
| CN101062362A (en) | Chinese traditional medicine agent for treating apoplectic hemiplegia and the sequela thereof | |
| CN103417774B (en) | Traditional Chinese medicine and preparing method and application thereof | |
| CN100493590C (en) | Astragalus leech collateral clearing capsule | |
| CN102133288A (en) | Chinese herba preparation for curing angina | |
| CN101912540A (en) | Medicament for treating cerebral infarction | |
| CN104000987A (en) | Traditional Chinese medicine composition for treating postnatal depression | |
| CN103830552A (en) | Traditional Chinese medicine composition for treating Meniere's disease | |
| CN102188688B (en) | Traditional Chinese medicine capable of treating cervical and lumbar vertebra hyperosteogeny | |
| CN104784398A (en) | Externally-applied ointment for treating stroke sequelae and preparation method thereof | |
| CN103417880A (en) | TCM composition and preparation method thereof | |
| Zhou et al. | Effect of combined acupuncture with Chinese medicine on overall function of patients with post-stroke depression | |
| CN103182037A (en) | Traditional Chinese medicine for treating rhinitis | |
| CN103285108B (en) | Chinese medicinal composition treating lumbago | |
| CN102579747B (en) | Anti-fatigue pharmaceutical composition | |
| CN101559134A (en) | Chinese materia medica preparation for treating rosacea | |
| CN102100777B (en) | Medicinal liquor for treating stroke sequela | |
| CN105213771A (en) | A kind of medicine for the treatment of apoplexy and preparation method thereof | |
| CN104800482A (en) | Traditional Chinese medicine composition for treating chest stuffiness and pains | |
| CN103638296A (en) | Application of traditional Chinese medicine for treating coronary heart disease | |
| CN104958504A (en) | Traditional Chinese medicine composition for preventing and treating sub-health and preparation method of traditional Chinese medicine composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110928 Termination date: 20151008 |
|
| EXPY | Termination of patent right or utility model |